Global Computational Pathology Market Size To Exceed USD 1.23 Billion by 2033 | CAGR of 8.19%
Category: Information & TechnologyGlobal Computational Pathology Market Size To Exceed USD 1.23 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Computational Pathology Market Size is Expected to Grow from USD 0.56 Billion in 2023 to USD 1.23 Billion by 2033, at a CAGR of 8.19% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 220 pages with 110 Market data tables and figures & charts from the report on the "Global Computational Pathology Market Size, Share, and COVID-19 Impact Analysis, By Component (Software and Services), By Application (Disease Diagnosis, Drug Discovery & Development, and Academic Research), By End User (Hospitals and Diagnostic Labs, Biotechnology and Pharmaceutical Companies, Academic and Research Institutes and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/computational-pathology-market
The computational pathology industry is the business that deals with the use of digital technologies, artificial intelligence (AI), and machine learning (ML) to analyze and interpret pathology data to diagnose diseases and conduct research. Moreover, the growing prevalence of chronic diseases like cancer, cardiovascular diseases, and diabetes is raising the demand for sophisticated diagnostic technology. Computational pathology software is essential for early disease detection and personalized treatment, especially in oncology, hence driving market growth. Machine learning and artificial intelligence have transformed the computational pathology market by offering robust image analysis software that increases the accuracy and speed of diagnosis. These technologies can detect intricate patterns in pathology slides, allowing pathologists to make more accurate and informed decisions, hence driving the growth of the market. However, certain healthcare professionals might resist the implementation of new technologies because of familiarity with conventional methods and apprehensions regarding the dependability of AI-based systems. Clinicians and pathologists might be reluctant to rely on automated tools rather than their judgment, hindering the incorporation of computational pathology into routine practices.
The software segment dominated the market in 2023 and is projected to grow at a substantial CAGR during the forecast period.
Based on the component, the computational pathology market is divided into software and services. Among these, the software segment dominated the market in 2023 and is projected to grow at a substantial CAGR during the forecast period. The growth is driven by software solutions that can be easily scaled and incorporated into hospital and diagnostic laboratory existing infrastructure, like electronic medical records (EMR) and laboratory information systems (LIS), drive growth. This makes the software an integral part of digital pathology adoption and accounts for its commanding share.
The disease diagnosis segment accounted for a significant share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the computational pathology market is divided into disease diagnosis, drug discovery & development, and academic research. Among these, the disease diagnosis segment accounted for a significant share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segmental growth is due to computational pathology enhances the speed and accuracy of disease diagnosis. Demand for more speedy, consistent results within hospitals and diagnostic laboratories has prompted extensive utilization of these systems, boosting the market share of this application segment.
The hospitals and diagnostic segment accounted for the biggest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the end user, the computational pathology market is divided into hospitals and diagnostic labs, biotechnology and pharmaceutical companies, academic and research institutes, and others. Among these, the hospitals and diagnostic segment accounted for the biggest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The growth is attributed to AI-driven computational pathology software helping pathologists make more precise diagnoses, particularly in intricate situations like cancer. Advanced image analysis through the use of technology ensures greater sensitivity and specificity, eliminating human error and allowing more accurate clinical decisions.
North America is expected to hold the majority share of the global computational pathology market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global computational pathology market during the forecast period. North America boasts a mature healthcare infrastructure with ubiquitous access to digital imaging, electronic health records, and integrated laboratory systems. These underpinnings enable early and widespread adoption of computational pathology solutions, facilitating scalable, AI-driven diagnostic workflows in hospitals, academic institutions, and diagnostic laboratories. The U.S. dominates global healthcare research and AI spending, with robust public and private sector funding. This investment promotes accelerated growth and testing of AI pathology technology, maintaining North America in the lead position in computational diagnostics and digital pathology platforms.
Asia Pacific is anticipated to grow at the fastest pace in the global computational pathology market during the forecast period. Asia-Pacific nations are rapidly modernizing their healthcare facilities. Numerous new hospitals and diagnostic laboratories are constructed with digital infrastructure from the beginning, making it possible to integrate AI and computational pathology technologies seamlessly to overcome scalability, talent shortages, and increasing patient volumes.
Major vendors in the global computational pathology market are Leica Biosystems Nussloch GmbH (Danaher), Hamamatsu Photonics, Inc., Koninklijke Philips N.V., Olympus Corporation, F. Hoffmann-La Roche Ltd., Mikroscan Technologies, Inc., Epredia (3DHISTECH Ltd.), Visiopharm A/S, Proscia Inc., Tempus, Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In July 2024, Proscia's new Concentriq AP platform added multi-AI workflows, allowing simultaneous analysis from multiple AI tools. It also includes DICOM image support, improved third-party AI integration, and multilingual support to fuel complete lab digitization and enhance diagnostic efficiency.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the computational pathology market based on the below-mentioned segments:
Global Computational Pathology Market, By Component
- Software
- Services
Global Computational Pathology Market, By Application
- Disease Diagnosis
- Drug Discovery & Development
- Academic Research
Global Computational Pathology Market, By End User
- Hospitals and Diagnostic Labs
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
- Others
Global Computational Pathology Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?